These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26334528)

  • 1. A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers.
    Oosterhoff M; van der Maas ME; Steuten LM
    Appl Health Econ Health Policy; 2016 Feb; 14(1):51-65. PubMed ID: 26334528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence synthesis to inform model-based cost-effectiveness evaluations of diagnostic tests: a methodological review of health technology assessments.
    Shinkins B; Yang Y; Abel L; Fanshawe TR
    BMC Med Res Methodol; 2017 Apr; 17(1):56. PubMed ID: 28410588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review.
    Seo MK; Cairns J
    BMC Cancer; 2021 Sep; 21(1):980. PubMed ID: 34470603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist.
    Doble B; Tan M; Harris A; Lorgelly P
    Expert Rev Mol Diagn; 2015 Feb; 15(2):235-54. PubMed ID: 25142227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
    Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
    Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slum upgrading strategies involving physical environment and infrastructure interventions and their effects on health and socio-economic outcomes.
    Turley R; Saith R; Bhan N; Rehfuess E; Carter B
    Cochrane Database Syst Rev; 2013 Jan; (1):CD010067. PubMed ID: 23440845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.
    Bereza BG; Machado M; Einarson TR
    Clin Ther; 2009 Jun; 31(6):1279-308. PubMed ID: 19695395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
    Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
    Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
    Frampton GK; Jones J; Rose M; Payne L
    Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of HIV pre-exposure prophylaxis strategies: protocol for a methodological systematic review and quantitative synthesis.
    Thavorn K; Kugathasan H; Tan DHS; Moqueet N; Baral SD; Skidmore B; MacFadden D; Simkin A; Mishra S
    Syst Rev; 2018 Mar; 7(1):47. PubMed ID: 29544530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality?
    Aguiar PM; Lima TM; Storpirtis S
    J Clin Pharm Ther; 2016 Apr; 41(2):189-97. PubMed ID: 27009796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
    Crathorne L; Huxley N; Haasova M; Snowsill T; Jones-Hughes T; Hoyle M; Briscoe S; Coelho H; Long L; Medina-Lara A; Mujica-Mota R; Napier M; Hyde C
    Health Technol Assess; 2016 Feb; 20(13):1-588, v-vi. PubMed ID: 26907163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of international coverage and pricing strategies for personalized medicine and orphan drugs.
    Degtiar I
    Health Policy; 2017 Dec; 121(12):1240-1248. PubMed ID: 29033060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis.
    Westwood M; Ramaekers B; Lang S; Armstrong N; Noake C; de Kock S; Joore M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Sep; 20(67):1-178. PubMed ID: 27623692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis.
    Hawton A; Shearer J; Goodwin E; Green C
    Appl Health Econ Health Policy; 2013 Aug; 11(4):331-41. PubMed ID: 23637055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic mapping review about costs and economic evaluations of skin conditions and diseases in the aged.
    Lichterfeld-Kottner A; Hahnel E; Blume-Peytavi U; Kottner J
    J Tissue Viability; 2017 Feb; 26(1):6-19. PubMed ID: 27544020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of model-based economic evaluations of diagnostic and therapeutic strategies for lower extremity artery disease.
    Vaidya A; Joore MA; ten Cate-Hoek AJ; Kleinegris MC; ten Cate H; Severens JL
    Thromb Haemost; 2014 Jan; 111(1):19-28. PubMed ID: 24108319
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.